CurveBeam Announces New Validated Protocols for LineUP™ Weight Bearing CT Imaging System

HATFIELD, Pa., Sept. 10, 2019 /PRNewswire/ — CurveBeam, a leader in extremity CT imaging, announced it has developed and validated protocols for the LineUP weight bearing CT imaging system that are compatible with Wright Medical Group’s PROPHECY™ Preoperative Navigation System and portfolio of total ankle replacement implants.  Hospitals and orthopedic practices selected to participate in a controlled release will be able to submit LineUP scans to be used in PROPHECY’s virtual preoperative alignment process to create patient-specific surgical guides, with the potential for the protocol to be available to all LineUP users.

CurveBeam will showcase examples of how weight bearing computed tomography (WBCT) scans produced on the LineUP were utilized in Wright’s proprietary technology to model patients’ unique anatomy to determine implant component sizes and alignment at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Chicago from September 12 – 15, 2019.

Dr. Robert Santrock, an orthopedic surgeon at the West Virginia University Health System, will deliver a lecture at CurveBeam’s exhibit (#932) on Friday, September 13 to discuss how he used the LineUP composite knee-foot scan protocol with the PROPHECY system for his patients who are undergoing a total ankle arthroplasty procedure.

WVU elected to place the LineUP in the Orthopedic Department, which makes scheduling and performing scans for patients more convenient,” Dr. Santrock said. “I am delighted I am now able to use LineUP technology in conjunction with the PROPHECY Preoperative Navigation System.”

“The application of WBCT imaging to patient-specific surgical modeling holds tremendous potential to enhance the accuracy of preoperative plans and assessment of post-operative results. It has a tremendous potential to improve outcomes,” said Arun Singh, President & CEO of CurveBeam.

The Wright Medical PROPHECY system is used with Wright’s INFINITY™ and INBONE™ Total Ankle Replacement Systems and its INVISION™ Total Ankle Revision System.

The CurveBeam LineUP is a weight bearing Extremity CT imaging system. Its innovative design allows for a patient to be scanned while he/she is standing naturally on both feet. The AOFAS recommends weight bearing imaging when possible to get the most accurate assessment. The LineUP offers the largest field-of-view in its class, which allows for both distal limbs to be captured in a single scan.

The LineUP is compact, self-shielded and plugs into a standard wall outlet, making it ideal for point-of-care orthopedic settings. A study published in the International Journal of Diagnostic Imaging concluded, “[due to extremely low levels] radiation should not be a concern when considering the use of WBCT imaging for foot & ankle examination.”

For more information on CurveBeam’s extremity 3D imaging solutions, visit www.curvebeam.com.

About CurveBeam

CurveBeam researches, designs and manufactures cone beam CT imaging systems for the orthopedic specialties. CurveBeam’s corporate headquarters is located in Hatfield, Pennsylvania. The company was founded in 2009 and is privately owned and operated.

View original content to download multimedia:http://www.prnewswire.com/news-releases/curvebeam-announces-new-validated-protocols-for-lineup-weight-bearing-ct-imaging-system-300915257.html

SOURCE CurveBeam

Staff

Recent Posts

FendX Technologies Inc. to Present at the Emerging Growth Conference on April 4, 2024

Oakville, Ontario--(Newsfile Corp. - April 2, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

34 mins ago

Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx™ in patients withrecurrent pericarditis,…

34 mins ago

Cantargia Publishes Data Highlighting the Potential of CAN10 in Atherosclerosis

LUND, SWEDEN / ACCESSWIRE / April 2, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq…

2 hours ago

Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs

Spin-out unites three sites to create a leading global CDMO as further significant investments announced…

5 hours ago

MedMira Reports Second Quarter Results FY2024

HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today…

8 hours ago

FSD Pharma Announces Filing of Year-End 2023 Results

TORONTO, ON / ACCESSWIRE / April 1, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"…

8 hours ago